Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antidepressants
Pharma
Intra-Cellular moves closer to Caplyta depression expansion
With two positive data sets in hand, Intra-Cellular is waiting for a third readout by June to file for Caplyta in major depressive disorder.
Angus Liu
Apr 16, 2024 2:27pm
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
Pharma TV ad spend in 2021: Goodbye Humira, hello Dupixent
Jan 20, 2022 9:35am
AbbVie's Vraylar turns in mixed results in depression
Oct 29, 2021 11:17am
Teva launches first DTC for Austedo into competitive market
May 28, 2021 7:20am
AvKARE bottles mix antidepressant and ED med, triggering recall
Dec 14, 2020 10:10am
